Literature DB >> 7525449

Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis.

M S Benassi1, L Campanacci, G Gamberi, C Ferrari, P Picci, L Sangiorgi, M Campanacci.   

Abstract

Twenty-four cases of adamantinoma and 24 cases of osteofibrous dysplasia of the long bones were studied to evaluate the expression and distribution of cytokeratin (CK) subtypes in relation to histogenesis and differentiation. The immunohistochemical study was performed on tissue fixed in buffered formalin and embedded in paraffin wax utilizing antibodies to vimentin, factor VIII, epithelial membrane antigen and cytokeratins of different molecular weights. In all cases the vimentin antibody marked positively in stroma, endothelium and osteoblasts, while factor VIII expression was confined to endothelial cells. In 71% of adamantinomas, vimentin showed strong immunoreactivity in the tumour cells of nests and tubules. CKAE1/AE3 and CK19 were strongly expressed in all morphological patterns of adamantinoma emphasizing their epithelial origin, while the antibodies to CK8 and CK18 showed a high percentage of negative responses. In osteofibrous dysplasia the epithelial-like component was much smaller than in adamantinoma and was present in scattered islands composed of a few cell positive for CKAE1/AE3 and CK19 and negative for other keratins. These results suggest that these two lesions are of a similar histogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525449     DOI: 10.1111/j.1365-2559.1994.tb00600.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

Review 1.  Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma.

Authors:  Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2003-03-22       Impact factor: 2.199

2.  Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.

Authors:  Takeshi G Kashima; Arunthati Dongre; Adrienne M Flanagan; Pancras C W Hogendoorn; Richard Taylor; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2011-04-16       Impact factor: 4.064

3.  p63 expression in adamantinoma.

Authors:  Brendan C Dickson; Yair Gortzak; Robert S Bell; Peter C Ferguson; David J C Howarth; Jay S Wunder; Rita A Kandel
Journal:  Virchows Arch       Date:  2011-06-15       Impact factor: 4.064

4.  Adamantinoma of Tibia.

Authors:  S Satyanarayana; K Z Jawed; D Sirohi; J Sikdar
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Adamantinoma in childhood: report of six cases and review of the literature.

Authors:  Rick Van Rijn; Johannes Bras; Gerard Schaap; Henk van den Berg; Mario Maas
Journal:  Pediatr Radiol       Date:  2006-08-12

6.  Differentiated adamantinoma of the fibula: a rhabdoid variant.

Authors:  C Povýsil; A Kohout; K Urban; M Horák
Journal:  Skeletal Radiol       Date:  2004-03-04       Impact factor: 2.199

7.  Adamantinoma: an unusual bone tumour.

Authors:  Pedro Roque; Henry J Mankin; Andrew Rosenberg
Journal:  Chir Organi Mov       Date:  2008-11-15

8.  Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours.

Authors:  D Charles Mangham; Nicholas A Athanasou
Journal:  Clin Sarcoma Res       Date:  2011-07-25

9.  Treatment of osteofibrous dysplasia and associated lesions.

Authors:  Soo Bong Hahn; Sung Hun Kim; Nam Hoon Cho; Chul Jun Choi; Bom Soo Kim; Ho Jung Kang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

10.  Giant monostotic osteofibrous dysplasia of the ilium: A case report and review of literature.

Authors:  Yu-Bo Liu; Tian-Ming Zou
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.